Company Filing History:
1 out of 1 
1 out of 4 Years Active: 2013
Title: The Innovative Contributions of Cecilie Martin
Introduction
Cecilie Martin is a prominent inventor based in Dresden, Germany. She has made significant strides in the field of medical research, particularly in the treatment of infectious diseases. Her work focuses on the use of inhibitors of scavenger receptor class proteins, which has the potential to revolutionize how certain infections are treated.
Latest Patents
Cecilie Martin holds a patent titled "Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases." This invention relates to the use of inhibitors, specifically ScarB1, for the production of a medicament aimed at treating and preventing infections that involve liver cells and hematopoietic cells, with a particular emphasis on malaria. She has 1 patent to her name.
Career Highlights
Throughout her career, Cecilie has worked with several esteemed organizations. Notably, she has been associated with the Instituto De Medicina Molecular and the Faculdade De Medicina Da Universidade De Lisboa. Additionally, she has contributed her expertise at Cenix Bioscience GmbH, where she has furthered her research in the field.
Collaborations
Cecilie has collaborated with notable professionals in her field, including Michael Hannus and Maria M Mota. These collaborations have enriched her research and contributed to her innovative work.
Conclusion
Cecilie Martin's contributions to the field of medical research, particularly in the treatment of infectious diseases, highlight her role as an influential inventor. Her patent and collaborations reflect her commitment to advancing healthcare solutions.